Funding

XpertDox Raises $20M Series A to Expand Autonomous Medical Coding

mm
Add Unite.AI to your preferred sources on Google

XpertDox announced a $20 million Series A on November 11, 2026, according to Business Wire’s listing of the release. Savant Growth led the investment, with funding from its investment partner Kennet Partners, to scale the company’s AI medical-coding business for healthcare providers.

The announcement included an operating milestone: XpertDox said its XpertCoding platform codes more than 91% of the claims it receives without manual intervention. The software turns clinical documentation in a provider’s electronic health record into coded data. That figure measures the share of claims automated without human handling, separate from coding accuracy or submission speed.

How XpertCoding Handles Claims

XpertDox’s product documentation describes a hybrid-AI system that combines ensemble models, neural networks and symbolic reasoning with payer guidelines to code clinical encounters. A configurable claim scrubber applies payer-specific rules. The platform is designed to work across electronic medical record systems, extracting data and submitting claims automatically within existing workflows.

The accompanying Business Intelligence platform supplies the oversight layer. Its dashboard displays coded claims and performance metrics, while an audit trail tracks modifications made by the coding engine. Claims flagged for manual review appear in a separate queue with graphical information about hold reasons, and clinical-documentation tools identify gaps for feedback. Additional dashboards cover risk adjustment and outpatient quality measures.

These controls show the operational boundary of the automation figure. Flagged claims still require review, and staff can inspect what the engine changed, giving providers a way to supervise exceptions rather than relying solely on a headline automation percentage.

Commercial Model and Expansion

XpertDox reports adoption by more than 40 healthcare organizations, coding accuracy above 99%, more than 94% of claims submitted within 24 hours, and the remaining less than 6% submitted within 48 hours. The pricing model charges per claim, with zero upfront fees and a complimentary first month. That structure ties revenue to processed claim volume, making customer additions and usage central to the business the round is intended to scale.

The financing followed a September 10, 2026 announcement that expanded XpertDox’s commercial leadership. Jim Whelan joined as senior vice president of sales to lead provider-client acquisition, and Nick Pierce became senior vice president of strategic partnerships to develop partner relationships. The company identified health systems, federally qualified health centers, group purchasing organizations, management services organizations and other provider organizations as audiences for XpertCoding’s expansion.

The round supports a business with an established pricing model, reported customer adoption and newly expanded sales and partnership roles. The central question for XpertDox’s expansion is whether its reported automation, accuracy and submission speeds can be sustained across a larger mix of providers while preserving the review and audit controls that govern exceptions.

Evan Mercer is an AI-generated research agent at Unite.AI, covering AI startups, venture capital, and the funding dynamics shaping the next generation of technology companies. His reporting focuses on early-stage innovation, capital flows, and the strategic decisions founders and investors make as AI companies scale from concept to global impact.

With a strategic and analytical lens, Evan examines funding rounds, market positioning, and emerging trends across the AI startup ecosystem. He tracks how venture capital, corporate investment, and public markets intersect with breakthroughs in artificial intelligence, separating durable signals from short-term hype.

Articles authored by Evan Mercer are AI-generated and reviewed by Unite.AI’s editorial team to ensure accuracy, context, and responsible coverage of the global AI investment landscape